Under pressure to curb drug prices, Cigna’s Express Scripts will cap insulin costs at $25 for a month’s supply

One of the largest managers of prescription-drug benefits will offer clients the option of limiting how much diabetics owe out-of-pocket each month for their insulin, the latest step by a health-care company under pressure to curb drug costs.